Stanford University
Showing 1,651-1,660 of 6,229 Results
-
Anne L. Friedlander
Adjunct Professor
BioAnne L. Friedlander, Ph.D, is the Assistant Director of Stanford Lifestyle Medicine, an Adjunct Professor in the Program in Human Biology, and a member of the Wu Tsai Human Performance Alliance. She has served as the Director of the Exercise Physiology Lab, the Director of the Mobility Division within the Stanford Center on Longevity (SCL), and the Associate Director for Education within the Geriatric Research, Education and Clinical Center (GRECC) at the VA Palo Alto. Dr. Friedlander has broad research experience in the areas of enhancing human performance, environmental physiology, and using physical activity and mobility to promote healthy aging. She also consults regularly with companies interested in developing new products, programs and ideas in the fitness and wellness space. She is passionate about the benefits of movement on the aging process and specializes in giving talks translating scientific findings on physiology and exercise into practical applications for people.
-
Joshua Frieman
Professor of Particle Physics and Astrophysics and, by courtesy, of Physics
BioI carry out theoretical and observational research in cosmology on topics including dark energy, dark matter, and inflation, using tools such as large-scale structure, gravitational lensing, and supernovae, with increasing focus on the application of machine learning to the analysis of cosmic surveys. Cosmology is akin to archaeology on the grand scale: as an archaeologist uses pottery shards to reconstruct an ancient civilization and how it evolved, cosmologists use both small- and large-scale data to reconstruct the origin and evolution of the universe and to probe fundamental physics.
-
Judith Frydman
Donald Kennedy Chair in the School of Humanities and Sciences and Professor of Genetics
Current Research and Scholarly InterestsThe long term goal of our research is to understand how proteins fold in living cells. My lab uses a multidisciplinary approach to address fundamental questions about molecular chaperones, protein folding and degradation. In addition to basic mechanistic principles, we aim to define how impairment of cellular folding and quality control are linked to disease, including cancer and neurodegenerative diseases and examine whether reengineering chaperone networks can provide therapeutic strategies.
